Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive declineP. Murali Doraiswamy, Reisa A. Sperling, Robert E. Coleman et al.|Neurology|2012Cited by 228
<sup>18</sup>F‐flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: A multicenter studyDaniel R. Schonhaut, Gil D. Rabinovici, Corey T. McMillan et al.|Annals of Neurology|2017Cited by 175
Cortico-Amygdala Coupling as a Marker of Early Relapse Risk in Cocaine-Addicted IndividualsMeredith McHugh, Bryon Adinoff, Catherine H. Demers et al.|Frontiers in Psychiatry|2014Cited by 77